Hormone identified that limits liver fibrosis
Friday, October 14, 2016 - 09:21
in Health & Medicine
Nonalcoholic steatohepatitis (NASH) has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis. A research team has identified and clarified the mechanism for a hormone that limits the fibrosis associated with NASH and cirrhosis. This discovery has potential applications for the treatment of these conditions.